The
European Pharmacopoeia (Ph. Eur.) Commission adopted 11 new monographs at its
159th Session, which took place in Strasbourg on 21-22 November 2017:
A
monograph elaborated under the P4 procedure, Rotigotine (3014). This procedure
applies to substances still under patent protection.
The
first monograph on a multisource monoclonal antibody, Infliximab concentrated
solution (2928); a dedicated press release will be published soon.
Monographs
on Phenoxymethylpenicillin, benzathine (2636), Zoledronic acid monohydrate
(2743), Imidacloprid for veterinary use (2924), Podophyllotoxin (2750),
Sulfobutylbetadex sodium (2804), Concentrated solutions for haemofiltration and
haemodiafiltration (2770), Digitalis purpurea for homoeopathic preparations
(2705), Lightyellow sophora root (2440), Gastrodia rhizome (2721) and
Phytomenadione, racemic (3011).
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources